Precision Diagnosis and Treatment for Cancer

—— precision medication guidelines for colorectal cancer     
Indication: colorectal cancer

Relationship between cancer treatment and genetic testing

ctDNA liquid biopsy can reflect tumor gene mutation information more comprehensively.

  • ctDNA liquid biopsy
    can reflect current characteristic and progress of tumor more comprehensively

    ctDNA liquid biopsy
    can analyze molecular types of tumor more comprehensively

    Tissue biopsy will only detect limited subtypes of tumor because of tumor heterogeneity. ctDNA liquid biopsy can analyze molecular types of tumor more comprehensively.

Clinical Evidences

5 genes recommended in the NCCN guideline for the treatment of colorectal cancer

Advantages and characteristics

—— precision medication guidelines for colorectal cancer

Changshibo is a product tailored for Colorectal cancer patients;

Changshibo provides gene testing by next generation sequencing (NGS) method with peripheral blood or tissue sample;

Advanced detection techniques to ensure accurate and reliable data

Advanced detection techniques to ensure accurate and reliable data

Compnehensive probe design with high uniformity capture efficiency.

Researchers from Comprehensive Cancer Center of the Ohio State University have compared these two capturing sequencing methods, SeqCap and HaloPlex. The results show that coverage of SeqCap has lower standard deviation with more uniform and stable captures. Hence, all drug-related loci will be covered.

Case

Suite 903-908, HealthWork, No. 35 Huayuan North Rd., Haidian District, Beijing

info@genecast.com.cn

Follow WeChat public accounts and learn More

Copyright © 2014-2019 臻和(北京)科技有限公司 Genecast Biotechnology Co., Ltd. Design by Bobrand